The editors of the prestigious Annals of Internal Medicine just stated they they were shocked, shocked to find out that physicians occasiona...
Once More with Feeling - Amgen Again Settles Allegations of Misbranding, But Why Bother?
The Latest Settlement Biotechnology giant Amgen has just reached another settlement of allegations that it unfairly, deceptively or misleadi...
18.47.00
Abbott
Celgene
mission-hostile management
Pfizer
Sanofi-Aventis
Steward Health Care
tobacco
US Chamber of Commerce
WellPoint
With 10 Health Care Executives on it Board, US Chamber of Commerce Defends Big Tobacco Abroad
Tobacco , especially smoked in cigarettes, is generally recognized by health care professionals as having health hazards that greatly outwei...
The Latest Example of the Anechoic Effect - AllTrials US Initiative Launches to Deafening Media Silence
Every now and then, someone tries to persuade me how much more open discussion of various kinds of recent unpleasantness in health care has ...
14.34.00
aliromucab
evidence-based medicine
health care prices
manipulating clinical research
PCSK9 inhibitor
Praluent
Regeneron
Sanofi-Aventis
Praluent, the Next Expensive "Game Changer," Blockbuster," "New Hope," - But Not Yet Shown to Benefit Patients
Here we go again. The same month that it approved Entresto (look here ), the US Food and Drug Administration approved a new PCSK9 inhibitor...
Langganan:
Postingan (Atom)